Cephalon recently persuaded a federal judge in Delaware to dismiss a derivative suit filed by shareholder Jerald King, but her ruling describes a fascinating timeline of wrongdoing at the company. At ...

Cephalon developed a sugar-free version of its Actiq fentanyl painkiller lollipop but chose not to market it, despite reports from patients that the sugar in Actiq was rotting their teeth, a man ...

Cephalon, Inc., (Nasdaq: CEPH) today announced Frank Baldino, Jr., Ph.D., the company's Chairman and Chief Executive Officer, will take a temporary medical leave of ...

--Quarterly Sales of $712 Million Increased 32 Percent --Quarterly Basic Adjusted EPS of $2.20 Increased 41 Percent --Ex-US Sales Exceed 25 Percent of Worldwide Sales for the First Time FRAZER, Pa., ...

FRAZER, Pa., Aug. 10 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announced today that it has completed its previously announced acquisition of all of the ...

FRAZER, Pa., Jan. 28 /PRNewswire-FirstCall/ -- Cephalon, Inc., (NASDAQ: CEPH) today announced the promotion of three executives, Kevin Buchi, Wilco Groenhuysen and ...

Powerful cancer pain drugs were given to patients with other conditions who cannot tolerate them. A program to curb the practice was run by companies that sell the drugs. By Emily Baumgaertner The ...

Teva is buying Cephalon for $6.8 billion, thwarting a hostile takeover attempt by Valeant and bolstering the Jerusalem-based generics giant’s footing in the market for branded pharmaceuticals. Teva’s ...

NEW YORK, Sept 24 (Reuters) - U.S. regulators will review Cephalon Inc's Nuvigil sleep disorder drug on a priority basis for an additional use of treating excessive sleepiness tied to jet lag, the ...

BOSTON (Reuters) - Cephalon Inc will pay $425 million to settle criminal and civil charges that it illegally promoted three of its drugs, the U.S. Department of Justice said on Monday. Sign up here.